For breast cancer patients younger than 40, FDG-PET/CT shows promise
10/05/2014

Researchers at Memorial Sloan Kettering found that PET/CT imaging of patients younger than 40 who were initially diagnosed with stage I-III breast cancer resulted in change of diagnosis.

Some symptoms in human version of inherited form of intellectual disability could be eased by cancer drug
10/04/2014

Studying mice with a genetic change similar to what is found in Kabuki syndrome, an inherited disease of humans, Johns Hopkins researchers report they have used an anticancer drug to "open up" DNA...

Down syndrome: what is the current focus of research?
10/03/2014

In our follow-up to yesterday's Down Syndrome Awareness Month spotlight feature, we talk to some of the leading experts in Down syndrome research.

Progress for early detection of colon cancer
10/03/2014

Three years of successful collaboration between Luxembourg's researchers, clinicians and IBBL (Integrated BioBank of Luxembourg) have led to the discovery of 2 molecules potentially suitable for...

Preventing cervical cancer - New vaccine against HPV infections imminent
10/03/2014

Nine sub-types of the human papillomavirus are responsible for 85 per cent of pre-cancerous cells of the cervix.

Progress for early detection of colon cancer
10/03/2014

Three years of successful collaboration between Luxembourg's researchers, clinicians and IBBL (Integrated BioBank of Luxembourg) have led to the discovery of 2 molecules potentially suitable for...

Preventing cervical cancer - New vaccine against HPV infections imminent
10/03/2014

Nine sub-types of the human papillomavirus are responsible for 85 per cent of pre-cancerous cells of the cervix.

Researchers synthetize a molecule that opens new pathways for cancer treatment and drug discovery
10/03/2014

Researchers from the University of Barcelona (UB) have synthetized a compound proved to be a potent inducer of apoptosis in a broad spectrum of tumour cell lines.

International team of scientists has shown that more than 80 per cent of bowel cancers could be treated with existing drugs
10/03/2014

The study found that medicines called 'JAK inhibitors' halted tumour growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers.

Screening for Lynch syndrome in younger people who are diagnosed with bowel cancer would be cost-effective
10/03/2014

Screening for a genetic condition in younger people who are diagnosed with bowel cancer would be cost-effective for the NHS and prevent new cases in them and their relatives, new research has...